Pharmaceutical Industry Information Portal

HomeNews

News

Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate

Sanofi and GSK started enrollment in their Phase 3 clinical study to assess the safety, efficacy, and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine...

Karaganda pharmaceutical plant will produce extra 1,7 million doses of Sputnik V vaccine

The minister also revealed that the Karaganda pharmaceutical plant will produce extra 1,7 million doses of Sputnik V vaccine. They will be distributed among regions of the country according to the approved schedule.

Indian Panacea Biotec launches production of Sputnik V vaccine

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India, today...

NUST MISIS: Bioactive Implant Coatings Resistant to Most Bacterial Strains Are Obtained in Russia

Young scientists from NUST MISIS have presented multilayer antibacterial coatings with a prolonged effect and a universal spectrum of action. The coating is based...

Perm subsidiary of NPO Microgen to expand the production of vaccines and blood products

Rostec and the Perm Krai signed a memorandum on co-operation in implementation of two large investment projects. Within the partnership, a new vaccine production...

BIOCAD has received approval from the Chinese authorities to conduct clinical trials of prololimab for the treatment of cervical cancer and NSCLC

SPH BIOCAD, a joint venture with Shanghai Pharmaceuticals Holding, which is registered in Hong Kong and has a representative office in Shanghai, has received...
spot_img

Expert Articles

spot_img